Diamedica Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Diamedica Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Diamedica Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Diamedica Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $18k | 2.7k | 6.77 |
| 2025-12-31 | $22k | 2.7k | 7.96 |
| 2025-09-30 | $19k | 2.7k | 6.87 |
| 2025-06-30 | $11k | 2.7k | 3.90 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors